{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:03:37Z","timestamp":1783091017522,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS088653"],"award-info":[{"award-number":["NS088653"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences, College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM109005"],"award-info":[{"award-number":["P20GM109005"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.nbd.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T08:19:07Z","timestamp":1520324347000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"114","author":[{"given":"Karen K.","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duah","family":"Alkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norm","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kiaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"McCampbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.03.002_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: implications for clinical management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0010","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1093\/hmg\/ddu136","article-title":"Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"23","author":"Bros-Facer","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.002_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/acn3.179","article-title":"Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients","volume":"2","author":"Bruneteau","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mcn.2006.03.002","article-title":"The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease","volume":"32","author":"De Winter","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0025","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","article-title":"Antisense reduction of tau in adult mice protects against seizures","volume":"33","author":"DeVos","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.03.002_bb0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrd3853","article-title":"Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS","volume":"11","author":"Faruqi","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2018.03.002_bb0040","first-page":"686","article-title":"Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease","volume":"26","author":"Fil","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.002_bb0045","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.0906809106","article-title":"Gamma and alpha motor neurons distinguished by expression of transcription factor Err3","volume":"106","author":"Friese","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.002_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/NEN.0b013e3182496149","article-title":"Expression and activation of EphA4 in the human brain after traumatic injury","volume":"71","author":"Frugier","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/ejn.13054","article-title":"In vitro models for peripheral nerve regeneration","volume":"43","author":"Geuna","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0060","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1523\/JNEUROSCI.2981-04.2004","article-title":"Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice","volume":"24","author":"Goldshmit","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainresrev.2006.04.006","article-title":"Roles of Eph receptors and ephrins in the normal and damaged adult CNS","volume":"52","author":"Goldshmit","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2018.03.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024636","article-title":"EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice","volume":"6","author":"Goldshmit","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2018.03.002_bb0075","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0022-510X(97)00247-5","article-title":"The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies","volume":"152","author":"Gurney","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0080","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.03.002_bb0085","doi-asserted-by":"crossref","DOI":"10.3791\/53257","article-title":"A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS","author":"Hatzipetros","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2018.03.002_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","article-title":"Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS","volume":"236","author":"Heiman-Patterson","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s00415-006-0195-y","article-title":"Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London","volume":"253","author":"Johnston","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.20420","article-title":"Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity","volume":"57","author":"Jokic","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0105","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.embor.7400826","article-title":"The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model","volume":"7","author":"Jokic","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2018.03.002_bb0110","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/ejn.12677","article-title":"The Ephrin receptor EphA4 restricts axonal sprouting and enhances branching in the injured mouse optic nerve","volume":"40","author":"Joly","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0115","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1111\/ejn.12357","article-title":"Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration","volume":"38","author":"Kempf","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0120","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1242\/dev.074997","article-title":"Eph\/ephrin signalling during development","volume":"139","author":"Klein","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.nbd.2018.03.002_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.conb.2014.02.006","article-title":"Ephrin signalling in the developing nervous system","volume":"27","author":"Klein","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0130","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.03.002_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.conb.2009.04.009","article-title":"Synapse development and plasticity: roles of ephrin\/Eph receptor signaling","volume":"19","author":"Lai","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0140","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/hmg\/ddt073","article-title":"Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke","volume":"22","author":"Lemmens","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.002_bb0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrm2679","article-title":"The trip of the tip: understanding the growth cone machinery","volume":"10","author":"Lowery","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(16)30399-4","article-title":"Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Meininger","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuron.2005.04.004","article-title":"New exchanges in eph-dependent growth cone dynamics","volume":"46","author":"Murai","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.03.002_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn994","article-title":"Control of hippocampal dendritic spine morphology through ephrin-A3\/EphA4 signaling","volume":"6","author":"Murai","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.mcn.2003.08.006","article-title":"Targeting the EphA4 receptor in the nervous system with biologically active peptides","volume":"24","author":"Murai","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0170","doi-asserted-by":"crossref","first-page":"E2230","DOI":"10.1073\/pnas.1204386109","article-title":"A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke","volume":"109","author":"Overman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.002_bb0175","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1038\/ncomms9570","article-title":"The transcriptional landscape of age in human peripheral blood","volume":"6","author":"Peters","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.03.002_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13311-015-0344-z","article-title":"RNA-targeted therapeutics for ALS","volume":"12","author":"Reddy","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2018.03.002_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.002_bb0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2018.03.002_bb0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2018.03.002_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.002_bb0205","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","article-title":"EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans","volume":"18","author":"Van Hoecke","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.03.002_bb0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/NEN.0000000000000086","article-title":"Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"73","author":"Venkova","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.03.002_bb0215","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature11280","article-title":"Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis","volume":"488","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.002_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.chembiol.2017.01.006","article-title":"Potent and selective EphA4 agonists for the treatment of ALS","volume":"24","author":"Wu","year":"2017","journal-title":"Cell Chem. Biol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118300652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118300652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T03:23:19Z","timestamp":1589858599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118300652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":44,"alternative-id":["S0969996118300652"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.03.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}